詳細書目資料

資料來源: Google Book
11
0
0
0
0

Ways of regulating drugs in the 19th and 20th centuries [electronic resource]

  • 其他作者:
  • 其他題名:
    • Science, technology, and medicine in modern history
  • 出版: Houndmills, Basingstoke, Hampshire : Palgrave Macmillan
  • 叢書名: Science, technology and medicine in modern history
  • 主題: Drugs--standards , Pharmaceutical industry--Quality control. , Drugs--Law and legislation--History--19th century. , Drugs--Law and legislation--History--20th century. , Drug Industry--standards. , Drug and Narcotic Control--history. , History, 19th Century. , History, 20th Century. , Legislation, Pharmacy--history. , Pharmaceutical Preparations--standards , Quality Control , Electronic books.
  • ISBN: 9781137291523 (electronic bk.) 、 1137291524 (electronic bk.)
  • FIND@SFXID: CGU
  • 資料類型: 電子書
  • 內容註: Includes bibliographical references and index. Secrets, bureaucracy and the public: drug regulation in Prussia in the 19th century / Volker Hess -- Making Salvarsan. experimental therapy and the development and marketing of Salvarsan at the interface between science, clinic, industry and public health / Axel H�untelmann -- Professional and industrial regulation in France and Germany: the trajectories of plant extracts / Jean-Paul Gaudilli�ere -- Making risks visible: the science, politics and regulation of adverse drug reactions / Harry Marks -- Regulating drugs, regulating diseases: consumerism and the U.S. tolbutamide controversy / Jeremy Greene -- Thalidomide, drug safety regulation and the British Pharmaceutical Industry: the case of Imperial Chemical Industries / Viviane Quirke -- What's in a pill? on the informational enrichment of anti-cancer drugs / Alberto Cambrosio, Peter Keating, and Andrei Mogoutov -- Treating health risks or putting healthy women at risk: controversies around chemoprevention of breast cancer / Ilana Lowy -- AZT and Drug Regulatory Reform in the late Twentieth century US / Donna messner -- Professional, industrial and court regulation of drugs: the 1953 Stalinon case and Pharmaceutical Reform in postwar France / Christian Bonah -- Managing double binds in the pharmaceutical prescription market: the case of Halcion / Toine Pieters and Stephen Snelders -- Pharmaceutical patent law in-the-making: opposition and legal action by states, citizens and generics laboratories in Brazil and India / Maurice Cassier.
  • 摘要註: Among industrial goods, pharmaceuticals are those for which the concept of regulation has been most often applied. One reason for the pervasiveness of the idea of regulation is that therapeutic agents are not like other goods. Their sale and purchase constitute a very distinct market, the control and oversight of which is viewed as a means to protect public health and considered as a duty of the state since the early nineteenth century. Drug regulation thus usually focuses on actions taken by political bodies to control the technical activities of drug makers. As it developed into a large industry, drug making has become the focus of highly visible conflicts between capitalistic firms, physicians, patients, and public authorities. Other forms and targets of drug government have emerged, which not only target sales and marketing, but deal with the entire trajectory of drugs, i.e. research and development, mass production and preparation, circulation and prescription and routine clinical work. The essays assembled in this volume share the perspective that the historiography of science, technology, and medicine, therefore, needs a broader approach toward regulation; an approach taking into account the distinct social worlds involved in regulation, the forms of evidence and expertise mobilized, and the means of intervention chosen in order to tame drugs in factories, offices, consulting rooms and courts. Focusing on case studies, the volume explores the 'ways of regulating drugs', which surfaced in the 19th and 20th century, and play a central role in the present world of science, market and medicine.
  • 讀者標籤:
  • 引用連結:
  • Share:
  • 系統號: 005100085 | 機讀編目格式
  • 館藏資訊

    This collection takes the perspective that the historiography of science, technology, and medicine needs a broader approach toward regulation. The authors explore the distinct social worlds involved in regulation, the forms of evidence and expertise mobilized, and means of intervention chosen to tame drugs in factories, consulting rooms and courts.

    資料來源: Google Book
    延伸查詢 Google Books Amazon
    回到最上